3D Printed Heart Models Could Enable Non-Invasive Diagnosis of Aortic Stenosis
|
By MedImaging International staff writers Posted on 11 Apr 2023 |

Aortic stenosis is a condition characterized by calcified and thickened aortic heart valves, which impede blood flow. Existing methods for assessing the severity of aortic stenosis, like Doppler echocardiography, can be prone to uncontrolled errors and often necessitate invasive pressure measurements for patients. No, aortic flow phantoms could provide a potential solution to this issue.
Researchers at King’s College London (KCL, London, UK) have made progress in utilizing 3D printed heart models (phantoms) to simulate and investigate aortic stenosis. Computer modeling and 3D printing of aortic flow phantoms present an alternative to in vivo studies, which are associated with challenges in patient recruitment and potential procedural risks. In contrast, the simulated option allows for greater variations in blood pressure flow and drop. The researchers created a non-invasive technique for evaluating pressure recovery distance based on blood flow momentum using 4D Flow cardiovascular magnetic resonance (CMR). Their findings revealed that pressure recovery distances in aortic stenosis are longer than previously recognized, indicating a need to reevaluate currently adopted interventional practices.
Furthermore, the researchers developed and successfully tested a flow phantom compatible with MRI and ultrasound, which accurately simulates valve opening and closing in both healthy and diseased conditions and offers ground-truth pressure measurement. The team's findings suggest that the peak-to-peak pressure drop, a current metric for assessing the burden of aortic stenosis, may be influenced by factors unrelated to the valve, such as wave reflection, and should be reexamined in clinical practice.
“By developing valve models that behave like real human valves, new techniques which more accurately characterize the severity of disease can be developed and improved without disrupting patients' care,” said Harminder Gill, BM BCh.
“The decision on how and when to treat stenotic valves is complex and the diagnostic tools typically used in clinical routine have barely evolved during the past 50 years,” explained Joao Filipe Fernandes, PhD, Marie Skłodowska-Curie Early Stage Researcher in Personalized in-Silico Cardiology. “Thus, advances in the study of aortic stenosis patho-physiology are essential to provide a more comprehensive characterization of this condition. The non-invasive assessment of the pressure recovery distance allows the detection of invasive catheterization errors as well as understanding the vessel length required for hemodynamic homeostasis to be reached.”
“These advances will enable us to take well informed decision on the best balance between drugs and surgeries for people living with valve conditions,” added Prof. Pablo Lamata, Head of Cardiac Modeling and Imaging Biomarkers Group.
Related Links:
King’s College London
Latest MRI News
- Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
- AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
- AI Reconstruction Tool Speeds Dynamic Breast MRI and Improves Cancer Detection
- International Study Assesses AI for Prostate Cancer MRI Interpretation
- AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
- Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
- AI System Improves Accuracy of Cardiac MRI Interpretation
- Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
- Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
- AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
- AI MRI Tool Quantifies Muscle Fat to Assess Cardiometabolic Risk
- Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
- MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
- MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
- MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
- Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreUltrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read moreNuclear Medicine
view channel
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







